Skip to NavigationSkip to content

News

0
otsuka image
Drunken behaviour, unsubstantiated stats in tweets and journal advertising investigated by regulating arm
0
Amgen image
Risk of suicide ideation and behaviour changes prompts agreement termination
0
Canadian biotech building large production facility to scale-up its therapeutics
0
EMA image
First-in-class offerings come from the likes of Amgen, BMS and Janssen 

Features

cameron

The BIA, ABPI, MedCity and pharma insiders weigh in on what the industry’s relationship with the new Conservative government might look like